Eurofins Genomics US has opened a new oligonucleotide manufacturing facility, expanding its capacity to meet growing global demand for GMP-grade and research use oligonucleotides. The facility will ...
Aligos Therapeutics (Nasdaq: ALGS) has announced positive top-line results from the Phase IIa HERALD study of ALG-055009, a thyroid hormone receptor beta (THR-β) agonist, in metabolic-dysfunction ...